On this page · 9 sections
Miscellaneous topical agents topical cream (2%)

Delgocitinib topical

Generic name: delgocitinib topical

Brand names: Anzupgo

Last updated November 2, 2026 0 views
Share

What is delgocitinib topical?

Delgocitinib topical (for the skin) is used in adults to treat moderate to severe chronic eczema (atopic dermatitis) on the hands.

Delgocitinib topical is used after other treatments are not recommended, did not work, or stopped working.

Delgocitinib topical may also be used for other reasons not mentioned in this medication guide.

This section was rewritten for readability and reviewed for meaning.

How should I use delgocitinib topical?

Follow all directions on your prescription label and read all medication guides or instruction sheets. Use the lowest effective dose for your condition.

Do not take by mouth. Delgocitinib topical is for use only on the skin of the hands and wrists.

Wash and dry your hands or wrists before applying this medicine. Use a mild soap to clean the skin area to be treated.

Use only a small amount of medicine. Apply a thin layer twice a day to the affected areas and rub in gently.

If a caregiver applies delgocitinib topical for you, they should wash their hands after applying this medicine.

You may get infections more easily, even serious or fatal infections.

You will need frequent medical tests before and during treatment with delgocitinib topical.

Store at room temperature away from moisture and heat. Do not freeze.

This section was rewritten for readability and reviewed for meaning.

Warnings

Use only as directed. Inform your doctor if you are taking other medicines or have other medical conditions or allergies.

This section was rewritten for readability and reviewed for meaning.

Before taking this medicine

Before you start using delgocitinib topical, tell your doctor if you have any signs of infection such as fever, chills, shortness of breath, cough, body aches, tiredness, open sores or skin wounds, diarrhea, stomach pain, weight loss, painful urination, or coughing up blood.

Tell your doctor if you have or have ever had:

  • an active or chronic infection;
  • tuberculosis or have been near people who have tuberculosis;
  • herpes zoster (also called shingles);
  • hepatitis B or C;
  • any type of cancer;
  • if you recently received a vaccine or are scheduled to receive a vaccine;
  • high cholesterol; or
  • a heart attack, stroke, blood clot, or other heart problems.

Tell your doctor if you've had or been exposed to tuberculosis, or if you recently traveled. Some infections are more common in certain parts of the world, and you may have been exposed during travel.

Make sure you are current on all vaccines before you start using delgocitinib topical.

delgocitinib topical may increase your risk of certain types of skin cancer. Your healthcare provider will check your skin on a regular basis. Report any new or changing skin lesions.

It is not known if delgocitinib topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

Ask a doctor if it is safe to breastfeed while using this medicine.

If you breastfeed, avoid touching your nipple area right away after applying delgocitinib topical to your hands and wrists.

This section was rewritten for readability and reviewed for meaning.

Delgocitinib topical side effects

Get emergency medical help if you have signs of an allergic reaction: hives, trouble breathing, swelling of your face, lips, tongue, or throat.

Delgocitinib topical may cause serious side effects. Call your doctor immediately if you experience:

  • heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;
  • signs of a blood clot--sudden numbness or weakness (especially on one side of the body), severe headache, slurred speech, problems with vision or balance, chest pain, sudden cough or shortness of breath, dizziness, coughing up blood, pain, swelling, or warmth in one leg;
  • signs of infection--fever, chills, sore throat, body aches, unusual tiredness, loss of appetite, bruising or bleeding;
  • signs of tuberculosis--fever, cough, night sweats, loss of appetite, weight loss, and feeling very tired; or
  • signs of shingles or eczema herpeticum--flu-like symptoms, painful blistering rash.

Common side effects of delgocitinib topical may include:

  • pain, tingling, itching, or redness in the area of the skin where the medicine was applied;
  • skin and nail infections; or
  • low white blood cell counts.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

This section was rewritten for readability and reviewed for meaning.

Delgocitinib topical dosing information

Usual Adult Dose for Eczema:

Apply a thin layer topically twice a day to affected areas of the hands and wrists only. -Do not use more than 30 grams per 2 weeks OR 60 grams per month.Comments:-Prior to cream application, the affected areas should be cleaned and dried. -Limitations of use: Not recommended in combination with other Janus kinase (JAK) inhibitors or potent immunosuppressants. Use: For the topical treatment of moderate to severe chronic hand eczema in patients who have had an inadequate response to, or for whom topical corticosteroids are not advisable

What happens if I miss a dose?

Apply the medicine as soon as possible, but if it is nearly time for your next dose, skip the missed dose. Do not apply two doses at once.

This section was rewritten for readability and reviewed for meaning.

What happens if I overdose?

Seek emergency medical help or call the Poison Help line at 1-800-222-1222 if anyone has accidentally swallowed the medicine.

Delgocitinib topical may increase your risk of skin cancer. Avoid sunlight or tanning beds. Wear protective clothing and use sunscreen (SPF 30 or higher) when you are outside.

Avoid getting a "live" vaccine right before starting, during, or right after treatment with delgocitinib topical. Live vaccines include measles, mumps, rubella (MMR), rotavirus, typhoid, yellow fever, and varicella (chickenpox).

Avoid getting delgocitinib topical in your eyes, nose, mouth, or genitals. If contact happens, rinse well with water.

This section was rewritten for readability and reviewed for meaning.

What other drugs will affect delgocitinib topical?

Tell your doctor about all your other medicines, especially:

  • other JAK inhibitors like baricitinib, tofacitinib, upadacitinib, ruxolitinib; or
  • medicines that weaken the immune system.

This list is not complete. Other medicines may affect delgocitinib topical, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

This section was rewritten for readability and reviewed for meaning.

Related medicines

Before you take this medicine: the information on this page is general and may not cover your personal circumstances. Read the label supplied with your medicine and ask a pharmacist or doctor if you are unsure, especially if you are pregnant, breastfeeding, taking other medicines or managing a long-term condition.
General medicine information Consumer-friendly language

Content is provided for education and is not medical advice. See our medical disclaimer.